Kazakhstan plans to launch the production of modern anti-cancer medicines jointly with Chinese partners. The project involves two drugs for the treatment of blood disorders. According to Health Minister Akmaral Alnazarova, establishing production in Kazakhstan will help reduce the cost of the medicines and make modern treatment options more accessible to patients. Both drugs are expected to be registered by the end of the year. In the longer term, Kazakhstan aims to move from secondary packaging to a full production cycle, including the manufacturing of active pharmaceutical ingredients (APIs).
«Localization will then be carried out in stages through 2029. The production will serve not only the domestic market but also the entire Central Asian market, with these medicines expected to have significant export potential in the future. As of today, based on the results of the first six months, 251,000 patients are registered for regular medical supervision. Of these, 22,000 were newly diagnosed during the first eight months of this year,» noted Kazakh Health Minister Akmaral Alnazarova.
Related Articles
